FLAM
SAGE

First Light Asset Management’s Sage Therapeutics SAGE Stock Holding History

First Light Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-92,761
Closed -$7.39M – 54
2017
Q2 		$7.39M Sell
92,761
-704
-0.8% -$50.9K 2.48% 15
2017
Q1 		$6.64M Sell
93,465
-679
-0.7% -$39.8K 2.54% 14
2016
Q4 		$4.81M Buy
94,144
+107
+0.1% +$5.04K 2.11% 18
2016
Q3 		$4.33M Buy
+94,037
New +$3.83M 1.86% 24

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

First Light Asset Management's SAGE Position: Q3 2017 in Review

First Light Asset Management sold out of Sage Therapeutics (SAGE) in Q3 2017, closing a stake of 92,761 shares — an estimated $7.39M sold.

First Light Asset Management first reported a position in SAGE in Q3 2016 and held it in 4 quarters. The position peaked at $7.39M in Q2 2017. 174 funds tracked by Wall St. Rank hold SAGE as of Q3 2017.

  • First Light Asset Management reported no remaining Sage Therapeutics position as of Q3 2017 after selling out during the quarter.
  • First Light Asset Management sold 92,761 Sage Therapeutics shares in Q3 2017, an estimated $7.39M.
  • First Light Asset Management first reported a position in Sage Therapeutics in Q3 2016 and held it in 4 quarters.
  • First Light Asset Management's Sage Therapeutics position peaked at $7.39M in Q2 2017.
  • 174 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2017.

Based on First Light Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.